Global Hemostatic Sponge

Hemostatic Sponge Comprehensive Study by Application (Surgical Wound Care, General Wound Care), End-user (Hospitals, Clinics, Others), Component (Gelatin, Cellulose, Chitosan) Players and Region - Global Market Outlook to 2030

Hemostatic Sponge Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 4.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Hemostatic Sponge Market Overview:
The hemostatic sponge is made of absorbent and implantable collagen of bovine or porcine origin is white, sterile and non-toxic, free of foreign particles, burrs and sharp edges. It is generally useful for neurological applications near the spine, liver surgery and vascular surgery. It is easy to cut and shape. It is used during capillary bleeding, bleeding on the sheet, hemostasis of the puncture in hemodialysis and clean the navel with a rotational movement around it. As per latest study released by AMA Research, the Global Hemostatic Sponge market is expected to see growth rate of 4.9%

AttributesDetails
Study Period201-2030
Base Year2023
Forecast Period2024-2030
Historical Period201-2023
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Robust Increase in the Distribution Channels

Market Growth Drivers:
Increased Number of Surgeries Performed Worldwide, Increased Number of Hospitals and Clinics and Development of Healthcare Infrastructure in Emerging Economies

Challenges:
Increasing Competition in the Market

Restraints:
Fluctuations in the Raw Material Prices

Opportunities:
Growth in the Healthcare Industry, Increasing Demand from End-users and Adoption of Novel Technologies by Manufacturers

Competitive Landscape:
There are various companies that are operating in the new geographical regions by adopting various market growth initiatives such as mergers & acquisitions, expansions, investments, and others. There are various new market players are entering the market to capture market growth opportunities.
Some of the key players profiled in the report are CuraMedical B.V. (Netherlands), Pfizer Inc. (United States), Medtrade Products (United Kingdom), Unilene (United States), BioCer Entwicklungs-GmbH (Germany), Aegis Lifesciences (India), Axio Biosolutions Private (India), Gelita Medical GmbH (Germany), Equimedical B.V. (Netherlands) and Ethicon Inc. (United States). Additionally, following companies can also be profiled that are part of our coverage like Hemostasis, LLC (United States) and Symatese (France). Analyst at AMA Research see United States Players to retain maximum share of Global Hemostatic Sponge market by 2030. Considering Market by End-user, the sub-segment i.e. Hospitals will boost the Hemostatic Sponge market. Considering Market by Component, the sub-segment i.e. Gelatin will boost the Hemostatic Sponge market.

Latest Market Insights:
In February 2023, Baxter International Inc. announced a collaboration with Sangene Inc., a Chinese biotechnology company, to develop and commercialize Sangene's innovative hemostatic sponge, Sangene X-Gel, in select markets outside of China.

In January 2023, Medtronic plc launched its next-generation hemostatic product, QuickFlo Hemostatic Sheeting, designed for broad surgical applications to achieve rapid bleeding control.

What Can be Explored with the Hemostatic Sponge Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Hemostatic Sponge Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Hemostatic Sponge
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Hemostatic Sponge market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Hemostatic Sponge market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Hemostatic Sponge Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Application
  • Surgical Wound Care
  • General Wound Care
By End-user
  • Hospitals
  • Clinics
  • Others

By Component
  • Gelatin
  • Cellulose
  • Chitosan

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Number of Surgeries Performed Worldwide
      • 3.2.2. Increased Number of Hospitals and Clinics
      • 3.2.3. Development of Healthcare Infrastructure in Emerging Economies
    • 3.3. Market Challenges
      • 3.3.1. Increasing Competition in the Market
    • 3.4. Market Trends
      • 3.4.1. Robust Increase in the Distribution Channels
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Hemostatic Sponge, by Application, End-user, Component and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Hemostatic Sponge (Value)
      • 5.2.1. Global Hemostatic Sponge by: Application (Value)
        • 5.2.1.1. Surgical Wound Care
        • 5.2.1.2. General Wound Care
      • 5.2.2. Global Hemostatic Sponge by: End-user (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Others
      • 5.2.3. Global Hemostatic Sponge by: Component (Value)
        • 5.2.3.1. Gelatin
        • 5.2.3.2. Cellulose
        • 5.2.3.3. Chitosan
      • 5.2.4. Global Hemostatic Sponge Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Hemostatic Sponge (Volume)
      • 5.3.1. Global Hemostatic Sponge by: Application (Volume)
        • 5.3.1.1. Surgical Wound Care
        • 5.3.1.2. General Wound Care
      • 5.3.2. Global Hemostatic Sponge by: End-user (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Others
      • 5.3.3. Global Hemostatic Sponge by: Component (Volume)
        • 5.3.3.1. Gelatin
        • 5.3.3.2. Cellulose
        • 5.3.3.3. Chitosan
      • 5.3.4. Global Hemostatic Sponge Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Hemostatic Sponge (Price)
  • 6. Hemostatic Sponge: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. CuraMedical B.V. (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtrade Products (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Unilene (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioCer Entwicklungs-GmbH (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Aegis Lifesciences (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Axio Biosolutions Private (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Gelita Medical GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Equimedical B.V. (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Ethicon Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Hemostatic Sponge Sale, by Application, End-user, Component and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Hemostatic Sponge (Value)
      • 7.2.1. Global Hemostatic Sponge by: Application (Value)
        • 7.2.1.1. Surgical Wound Care
        • 7.2.1.2. General Wound Care
      • 7.2.2. Global Hemostatic Sponge by: End-user (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Others
      • 7.2.3. Global Hemostatic Sponge by: Component (Value)
        • 7.2.3.1. Gelatin
        • 7.2.3.2. Cellulose
        • 7.2.3.3. Chitosan
      • 7.2.4. Global Hemostatic Sponge Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Hemostatic Sponge (Volume)
      • 7.3.1. Global Hemostatic Sponge by: Application (Volume)
        • 7.3.1.1. Surgical Wound Care
        • 7.3.1.2. General Wound Care
      • 7.3.2. Global Hemostatic Sponge by: End-user (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Others
      • 7.3.3. Global Hemostatic Sponge by: Component (Volume)
        • 7.3.3.1. Gelatin
        • 7.3.3.2. Cellulose
        • 7.3.3.3. Chitosan
      • 7.3.4. Global Hemostatic Sponge Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Hemostatic Sponge (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Hemostatic Sponge: by Application(USD Million)
  • Table 2. Hemostatic Sponge Surgical Wound Care , by Region USD Million (2018-2023)
  • Table 3. Hemostatic Sponge General Wound Care , by Region USD Million (2018-2023)
  • Table 4. Hemostatic Sponge: by End-user(USD Million)
  • Table 5. Hemostatic Sponge Hospitals , by Region USD Million (2018-2023)
  • Table 6. Hemostatic Sponge Clinics , by Region USD Million (2018-2023)
  • Table 7. Hemostatic Sponge Others , by Region USD Million (2018-2023)
  • Table 8. Hemostatic Sponge: by Component(USD Million)
  • Table 9. Hemostatic Sponge Gelatin , by Region USD Million (2018-2023)
  • Table 10. Hemostatic Sponge Cellulose , by Region USD Million (2018-2023)
  • Table 11. Hemostatic Sponge Chitosan , by Region USD Million (2018-2023)
  • Table 12. South America Hemostatic Sponge, by Country USD Million (2018-2023)
  • Table 13. South America Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 14. South America Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 15. South America Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 16. Brazil Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 17. Brazil Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 18. Brazil Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 19. Argentina Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 20. Argentina Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 21. Argentina Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 22. Rest of South America Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 23. Rest of South America Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 24. Rest of South America Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 25. Asia Pacific Hemostatic Sponge, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 27. Asia Pacific Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 28. Asia Pacific Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 29. China Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 30. China Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 31. China Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 32. Japan Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 33. Japan Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 34. Japan Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 35. India Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 36. India Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 37. India Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 38. South Korea Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 39. South Korea Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 40. South Korea Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 41. Taiwan Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 42. Taiwan Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 43. Taiwan Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 44. Australia Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 45. Australia Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 46. Australia Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 50. Europe Hemostatic Sponge, by Country USD Million (2018-2023)
  • Table 51. Europe Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 52. Europe Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 53. Europe Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 54. Germany Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 55. Germany Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 56. Germany Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 57. France Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 58. France Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 59. France Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 60. Italy Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 61. Italy Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 62. Italy Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 63. United Kingdom Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 64. United Kingdom Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 65. United Kingdom Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 66. Netherlands Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 67. Netherlands Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 68. Netherlands Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 69. Rest of Europe Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 70. Rest of Europe Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 71. Rest of Europe Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 72. MEA Hemostatic Sponge, by Country USD Million (2018-2023)
  • Table 73. MEA Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 74. MEA Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 75. MEA Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 76. Middle East Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 77. Middle East Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 78. Middle East Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 79. Africa Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 80. Africa Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 81. Africa Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 82. North America Hemostatic Sponge, by Country USD Million (2018-2023)
  • Table 83. North America Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 84. North America Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 85. North America Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 86. United States Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 87. United States Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 88. United States Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 89. Canada Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 90. Canada Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 91. Canada Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 92. Mexico Hemostatic Sponge, by Application USD Million (2018-2023)
  • Table 93. Mexico Hemostatic Sponge, by End-user USD Million (2018-2023)
  • Table 94. Mexico Hemostatic Sponge, by Component USD Million (2018-2023)
  • Table 95. Hemostatic Sponge Sales: by Application(K Units)
  • Table 96. Hemostatic Sponge Sales Surgical Wound Care , by Region K Units (2018-2023)
  • Table 97. Hemostatic Sponge Sales General Wound Care , by Region K Units (2018-2023)
  • Table 98. Hemostatic Sponge Sales: by End-user(K Units)
  • Table 99. Hemostatic Sponge Sales Hospitals , by Region K Units (2018-2023)
  • Table 100. Hemostatic Sponge Sales Clinics , by Region K Units (2018-2023)
  • Table 101. Hemostatic Sponge Sales Others , by Region K Units (2018-2023)
  • Table 102. Hemostatic Sponge Sales: by Component(K Units)
  • Table 103. Hemostatic Sponge Sales Gelatin , by Region K Units (2018-2023)
  • Table 104. Hemostatic Sponge Sales Cellulose , by Region K Units (2018-2023)
  • Table 105. Hemostatic Sponge Sales Chitosan , by Region K Units (2018-2023)
  • Table 106. South America Hemostatic Sponge Sales, by Country K Units (2018-2023)
  • Table 107. South America Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 108. South America Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 109. South America Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 110. Brazil Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 111. Brazil Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 112. Brazil Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 113. Argentina Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 114. Argentina Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 115. Argentina Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 116. Rest of South America Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 117. Rest of South America Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 118. Rest of South America Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 119. Asia Pacific Hemostatic Sponge Sales, by Country K Units (2018-2023)
  • Table 120. Asia Pacific Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 121. Asia Pacific Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 122. Asia Pacific Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 123. China Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 124. China Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 125. China Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 126. Japan Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 127. Japan Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 128. Japan Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 129. India Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 130. India Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 131. India Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 132. South Korea Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 133. South Korea Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 134. South Korea Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 135. Taiwan Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 136. Taiwan Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 137. Taiwan Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 138. Australia Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 139. Australia Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 140. Australia Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 141. Rest of Asia-Pacific Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 142. Rest of Asia-Pacific Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 143. Rest of Asia-Pacific Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 144. Europe Hemostatic Sponge Sales, by Country K Units (2018-2023)
  • Table 145. Europe Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 146. Europe Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 147. Europe Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 148. Germany Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 149. Germany Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 150. Germany Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 151. France Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 152. France Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 153. France Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 154. Italy Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 155. Italy Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 156. Italy Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 157. United Kingdom Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 158. United Kingdom Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 159. United Kingdom Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 160. Netherlands Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 161. Netherlands Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 162. Netherlands Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 163. Rest of Europe Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 164. Rest of Europe Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 165. Rest of Europe Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 166. MEA Hemostatic Sponge Sales, by Country K Units (2018-2023)
  • Table 167. MEA Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 168. MEA Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 169. MEA Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 170. Middle East Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 171. Middle East Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 172. Middle East Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 173. Africa Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 174. Africa Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 175. Africa Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 176. North America Hemostatic Sponge Sales, by Country K Units (2018-2023)
  • Table 177. North America Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 178. North America Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 179. North America Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 180. United States Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 181. United States Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 182. United States Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 183. Canada Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 184. Canada Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 185. Canada Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 186. Mexico Hemostatic Sponge Sales, by Application K Units (2018-2023)
  • Table 187. Mexico Hemostatic Sponge Sales, by End-user K Units (2018-2023)
  • Table 188. Mexico Hemostatic Sponge Sales, by Component K Units (2018-2023)
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Hemostatic Sponge: by Application(USD Million)
  • Table 200. Hemostatic Sponge Surgical Wound Care , by Region USD Million (2025-2030)
  • Table 201. Hemostatic Sponge General Wound Care , by Region USD Million (2025-2030)
  • Table 202. Hemostatic Sponge: by End-user(USD Million)
  • Table 203. Hemostatic Sponge Hospitals , by Region USD Million (2025-2030)
  • Table 204. Hemostatic Sponge Clinics , by Region USD Million (2025-2030)
  • Table 205. Hemostatic Sponge Others , by Region USD Million (2025-2030)
  • Table 206. Hemostatic Sponge: by Component(USD Million)
  • Table 207. Hemostatic Sponge Gelatin , by Region USD Million (2025-2030)
  • Table 208. Hemostatic Sponge Cellulose , by Region USD Million (2025-2030)
  • Table 209. Hemostatic Sponge Chitosan , by Region USD Million (2025-2030)
  • Table 210. South America Hemostatic Sponge, by Country USD Million (2025-2030)
  • Table 211. South America Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 212. South America Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 213. South America Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 214. Brazil Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 215. Brazil Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 216. Brazil Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 217. Argentina Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 218. Argentina Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 219. Argentina Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 220. Rest of South America Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 221. Rest of South America Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 222. Rest of South America Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 223. Asia Pacific Hemostatic Sponge, by Country USD Million (2025-2030)
  • Table 224. Asia Pacific Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 225. Asia Pacific Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 226. Asia Pacific Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 227. China Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 228. China Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 229. China Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 230. Japan Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 231. Japan Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 232. Japan Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 233. India Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 234. India Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 235. India Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 236. South Korea Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 237. South Korea Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 238. South Korea Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 239. Taiwan Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 240. Taiwan Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 241. Taiwan Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 242. Australia Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 243. Australia Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 244. Australia Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 245. Rest of Asia-Pacific Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 246. Rest of Asia-Pacific Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 247. Rest of Asia-Pacific Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 248. Europe Hemostatic Sponge, by Country USD Million (2025-2030)
  • Table 249. Europe Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 250. Europe Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 251. Europe Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 252. Germany Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 253. Germany Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 254. Germany Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 255. France Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 256. France Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 257. France Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 258. Italy Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 259. Italy Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 260. Italy Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 261. United Kingdom Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 262. United Kingdom Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 263. United Kingdom Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 264. Netherlands Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 265. Netherlands Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 266. Netherlands Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 267. Rest of Europe Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 268. Rest of Europe Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 269. Rest of Europe Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 270. MEA Hemostatic Sponge, by Country USD Million (2025-2030)
  • Table 271. MEA Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 272. MEA Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 273. MEA Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 274. Middle East Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 275. Middle East Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 276. Middle East Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 277. Africa Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 278. Africa Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 279. Africa Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 280. North America Hemostatic Sponge, by Country USD Million (2025-2030)
  • Table 281. North America Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 282. North America Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 283. North America Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 284. United States Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 285. United States Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 286. United States Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 287. Canada Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 288. Canada Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 289. Canada Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 290. Mexico Hemostatic Sponge, by Application USD Million (2025-2030)
  • Table 291. Mexico Hemostatic Sponge, by End-user USD Million (2025-2030)
  • Table 292. Mexico Hemostatic Sponge, by Component USD Million (2025-2030)
  • Table 293. Hemostatic Sponge Sales: by Application(K Units)
  • Table 294. Hemostatic Sponge Sales Surgical Wound Care , by Region K Units (2025-2030)
  • Table 295. Hemostatic Sponge Sales General Wound Care , by Region K Units (2025-2030)
  • Table 296. Hemostatic Sponge Sales: by End-user(K Units)
  • Table 297. Hemostatic Sponge Sales Hospitals , by Region K Units (2025-2030)
  • Table 298. Hemostatic Sponge Sales Clinics , by Region K Units (2025-2030)
  • Table 299. Hemostatic Sponge Sales Others , by Region K Units (2025-2030)
  • Table 300. Hemostatic Sponge Sales: by Component(K Units)
  • Table 301. Hemostatic Sponge Sales Gelatin , by Region K Units (2025-2030)
  • Table 302. Hemostatic Sponge Sales Cellulose , by Region K Units (2025-2030)
  • Table 303. Hemostatic Sponge Sales Chitosan , by Region K Units (2025-2030)
  • Table 304. South America Hemostatic Sponge Sales, by Country K Units (2025-2030)
  • Table 305. South America Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 306. South America Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 307. South America Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 308. Brazil Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 309. Brazil Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 310. Brazil Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 311. Argentina Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 312. Argentina Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 313. Argentina Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 314. Rest of South America Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 315. Rest of South America Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 316. Rest of South America Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 317. Asia Pacific Hemostatic Sponge Sales, by Country K Units (2025-2030)
  • Table 318. Asia Pacific Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 319. Asia Pacific Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 320. Asia Pacific Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 321. China Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 322. China Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 323. China Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 324. Japan Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 325. Japan Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 326. Japan Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 327. India Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 328. India Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 329. India Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 330. South Korea Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 331. South Korea Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 332. South Korea Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 333. Taiwan Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 334. Taiwan Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 335. Taiwan Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 336. Australia Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 337. Australia Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 338. Australia Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 339. Rest of Asia-Pacific Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 340. Rest of Asia-Pacific Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 341. Rest of Asia-Pacific Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 342. Europe Hemostatic Sponge Sales, by Country K Units (2025-2030)
  • Table 343. Europe Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 344. Europe Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 345. Europe Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 346. Germany Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 347. Germany Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 348. Germany Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 349. France Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 350. France Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 351. France Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 352. Italy Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 353. Italy Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 354. Italy Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 355. United Kingdom Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 356. United Kingdom Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 357. United Kingdom Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 358. Netherlands Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 359. Netherlands Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 360. Netherlands Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 361. Rest of Europe Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 362. Rest of Europe Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 363. Rest of Europe Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 364. MEA Hemostatic Sponge Sales, by Country K Units (2025-2030)
  • Table 365. MEA Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 366. MEA Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 367. MEA Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 368. Middle East Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 369. Middle East Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 370. Middle East Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 371. Africa Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 372. Africa Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 373. Africa Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 374. North America Hemostatic Sponge Sales, by Country K Units (2025-2030)
  • Table 375. North America Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 376. North America Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 377. North America Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 378. United States Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 379. United States Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 380. United States Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 381. Canada Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 382. Canada Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 383. Canada Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 384. Mexico Hemostatic Sponge Sales, by Application K Units (2025-2030)
  • Table 385. Mexico Hemostatic Sponge Sales, by End-user K Units (2025-2030)
  • Table 386. Mexico Hemostatic Sponge Sales, by Component K Units (2025-2030)
  • Table 387. Research Programs/Design for This Report
  • Table 388. Key Data Information from Secondary Sources
  • Table 389. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Hemostatic Sponge: by Application USD Million (2018-2023)
  • Figure 5. Global Hemostatic Sponge: by End-user USD Million (2018-2023)
  • Figure 6. Global Hemostatic Sponge: by Component USD Million (2018-2023)
  • Figure 7. South America Hemostatic Sponge Share (%), by Country
  • Figure 8. Asia Pacific Hemostatic Sponge Share (%), by Country
  • Figure 9. Europe Hemostatic Sponge Share (%), by Country
  • Figure 10. MEA Hemostatic Sponge Share (%), by Country
  • Figure 11. North America Hemostatic Sponge Share (%), by Country
  • Figure 12. Global Hemostatic Sponge: by Application K Units (2018-2023)
  • Figure 13. Global Hemostatic Sponge: by End-user K Units (2018-2023)
  • Figure 14. Global Hemostatic Sponge: by Component K Units (2018-2023)
  • Figure 15. South America Hemostatic Sponge Share (%), by Country
  • Figure 16. Asia Pacific Hemostatic Sponge Share (%), by Country
  • Figure 17. Europe Hemostatic Sponge Share (%), by Country
  • Figure 18. MEA Hemostatic Sponge Share (%), by Country
  • Figure 19. North America Hemostatic Sponge Share (%), by Country
  • Figure 20. Global Hemostatic Sponge share by Players 2023 (%)
  • Figure 21. Global Hemostatic Sponge share by Players (Top 3) 2023(%)
  • Figure 22. Global Hemostatic Sponge share by Players (Top 5) 2023(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. CuraMedical B.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 25. CuraMedical B.V. (Netherlands) Revenue: by Geography 2023
  • Figure 26. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Pfizer Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Medtrade Products (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Medtrade Products (United Kingdom) Revenue: by Geography 2023
  • Figure 30. Unilene (United States) Revenue, Net Income and Gross profit
  • Figure 31. Unilene (United States) Revenue: by Geography 2023
  • Figure 32. BioCer Entwicklungs-GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 33. BioCer Entwicklungs-GmbH (Germany) Revenue: by Geography 2023
  • Figure 34. Aegis Lifesciences (India) Revenue, Net Income and Gross profit
  • Figure 35. Aegis Lifesciences (India) Revenue: by Geography 2023
  • Figure 36. Axio Biosolutions Private (India) Revenue, Net Income and Gross profit
  • Figure 37. Axio Biosolutions Private (India) Revenue: by Geography 2023
  • Figure 38. Gelita Medical GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 39. Gelita Medical GmbH (Germany) Revenue: by Geography 2023
  • Figure 40. Equimedical B.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 41. Equimedical B.V. (Netherlands) Revenue: by Geography 2023
  • Figure 42. Ethicon Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 43. Ethicon Inc. (United States) Revenue: by Geography 2023
  • Figure 44. Global Hemostatic Sponge: by Application USD Million (2025-2030)
  • Figure 45. Global Hemostatic Sponge: by End-user USD Million (2025-2030)
  • Figure 46. Global Hemostatic Sponge: by Component USD Million (2025-2030)
  • Figure 47. South America Hemostatic Sponge Share (%), by Country
  • Figure 48. Asia Pacific Hemostatic Sponge Share (%), by Country
  • Figure 49. Europe Hemostatic Sponge Share (%), by Country
  • Figure 50. MEA Hemostatic Sponge Share (%), by Country
  • Figure 51. North America Hemostatic Sponge Share (%), by Country
  • Figure 52. Global Hemostatic Sponge: by Application K Units (2025-2030)
  • Figure 53. Global Hemostatic Sponge: by End-user K Units (2025-2030)
  • Figure 54. Global Hemostatic Sponge: by Component K Units (2025-2030)
  • Figure 55. South America Hemostatic Sponge Share (%), by Country
  • Figure 56. Asia Pacific Hemostatic Sponge Share (%), by Country
  • Figure 57. Europe Hemostatic Sponge Share (%), by Country
  • Figure 58. MEA Hemostatic Sponge Share (%), by Country
  • Figure 59. North America Hemostatic Sponge Share (%), by Country
List of companies from research coverage that are profiled in the study
  • CuraMedical B.V. (Netherlands)
  • Pfizer Inc. (United States)
  • Medtrade Products (United Kingdom)
  • Unilene (United States)
  • BioCer Entwicklungs-GmbH (Germany)
  • Aegis Lifesciences (India)
  • Axio Biosolutions Private (India)
  • Gelita Medical GmbH (Germany)
  • Equimedical B.V. (Netherlands)
  • Ethicon Inc. (United States)
Additional players considered in the study are as follows:
Hemostasis, LLC (United States) , Symatese (France)
Select User Access Type

Key Highlights of Report


Mar 2024 219 Pages 51 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Hemostatic Sponge Quantitative research analysis
Global Hemostatic Sponge Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Hemostatic Sponge market are CuraMedical B.V. (Netherlands), Pfizer Inc. (United States), Medtrade Products (United Kingdom), Unilene (United States), BioCer Entwicklungs-GmbH (Germany), Aegis Lifesciences (India), Axio Biosolutions Private (India), Gelita Medical GmbH (Germany), Equimedical B.V. (Netherlands) and Ethicon Inc. (United States), to name a few.
"Robust Increase in the Distribution Channels" is seen as one of major influencing trends for Hemostatic Sponge Market during projected period 2023-2030.

Know More About Global Hemostatic Sponge Report?

Have a Query? Click Here

Other Related Reports

Bacillus Coagulans Comprehensive Study by Type (Pharmaceutical grade, Food Grade, Others), Application (Pharmaceuticals, Food Industry, Feed Industry, Others), Distribution Channel (Hypermarkets/Supe...
$ 3450
Medical Gas Comprehensive Study by Type (Oxygen, Nitrous Oxide, Medical Air, Others), Application (Hospitals & Clinics, Home Healthcare, Universities & Research Institutions, Pharmaceutical & Biotech...
$ 3500
Surgical Gowns Comprehensive Study by Type (Reusable, Disposable), End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Clinics, Others), Distribution Channel (Online Sales, Retail ...
$ 3350
Neuroprosthetics Comprehensive Study by Type (Output Neural Prosthetics, Input Neural Prosthetics), Application (Motor Neuron Disorders, Physiological Disorders, Cognitive Disorders), Technology (Dee...
$ 3650
Dental Biomaterials Comprehensive Study by Type (Metallic Biomaterials, Titanium, Stainless Steel, Chromium Alloys, Other Metallic Biomaterials, Metal-ceramic Biomaterials, Ceramic Biomaterials, Poly...
$ 3750
Orthodontic Brackets  Comprehensive Study by Type (Conventional Brackets, Self-ligating Brackets, Lingual Brackets), Application (Children, Adult), Material (Metallic, Aesthetic {Plastic, Ceramic}, ...
$ 3450